Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05472545 · ClinicalTrials.gov registry record · NA

Dyadic Neurofeedback for Development of Healthy Emotion Regulation in Youth

A NA study of Emotional Regulation, sponsored by Oklahoma State University Center for Health Sciences.

Active
Registry status
NA
Development phase
210
Enrollment target
1
Study location

NCT05472545 is a NA study of Emotional Regulation that is active but no longer recruiting, run by Oklahoma State University Center for Health Sciences. The registered enrollment target is 210 participants, below the 458-participant average among 11 other Emotional Regulation trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05472545, a NA study of Emotional Regulation, is active but no longer recruiting, sponsored by Oklahoma State University Center for Health Sciences.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
210 participants
Enrollment target
1
Study location

Study Summary

This study will examine the effect of a real-time functional magnetic resonance imaging (fMRI) dyadic neurofeedback protocol with mothers and their adolescent daughters. Mothers in the experimental condition will view a moving bar showing their daughters' brain activity on a computer screen while talking to their daughters.

Conditions Studied

Interventions

  • BEHAVIORAL Neurofeedback

Study Locations (1)

Oklahoma

  • Hardesty Center for Clinical Research and Neuroscience - Tulsa

Trial Details

FieldValue
Enrollment Target 210 participants
Start Date 2023-03-13
Est. Completion 2025-09
Phase NA

What the Registry Record Tells You About NCT05472545

The ClinicalTrials.gov registry entry for NCT05472545 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 210 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 458-participant average among 11 other Emotional Regulation trials with a reported enrollment target (54% lower). The listed sponsor is Oklahoma State University Center for Health Sciences, which has 24 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Emotional Regulation appearing as the primary indexed condition, and to 1 intervention - of which Neurofeedback is the first listed.

NCT05472545 reports 1 study location spanning 1 distinct geographic area - top geographies include Oklahoma.

Frequently Asked Questions

What is clinical trial NCT05472545 about?

NCT05472545 is a clinical study titled "Dyadic Neurofeedback for Development of Healthy Emotion Regulation in Youth". This study will examine the effect of a real-time functional magnetic resonance imaging (fMRI) dyadic neurofeedback protocol with mothers and their adolescent daughters. Mothers in the experimental condition will view a moving bar showing their daughters' brain activity on a computer screen while ta...

What is the current status of trial NCT05472545?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 210 participants. The study started on 2023-03-13. Estimated completion is 2025-09.

What conditions does trial NCT05472545 study?

This clinical trial studies the following conditions: Emotional Regulation.

What interventions are being tested in trial NCT05472545?

The interventions under investigation include: Neurofeedback (BEHAVIORAL).

Who is sponsoring clinical trial NCT05472545?

This trial is sponsored by Oklahoma State University Center for Health Sciences, which has 24 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05472545 being conducted?

This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Emotional Regulation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.